Abhishek Sinha, Rinku Garg


Introduction: Type II Diabetes Mellitus is one of the diseases which is expected to reach epidemic proportions in the Indian subcontinent in the coming years. HbA1c levels are used to assess the severity of the disease universally. In the present study we have tried to test for the relationship between the duration of diabetes, BMI of the patients and blood glucose with HbA1c levels.

Material and Methods: 87 Type II Diabetes Mellitus patients were recruited for this study. Their anthropometric and disease history was noted down and HbA1c and blood glucose levels were estimated biochemically.

Statistical Analysis: Data collected was entered in to MS Excel and analyzed by SPSS 25 software for relationship of variables with HbA1c by correlation test and whether these variables are predictors of HbA1c by regression tests.

Result: The duration of diabetes and BMI were not correlated with HbA1c levels, however FBG AND PPG were correlated significantly with HbA1c levels. Also BMI, duration of diabetes, FBG and PPG were found to be independent predictors of HbA1c levels in these patients.

Discussion: BMI and duration of diabetes are not correlated with HbA1c levels in a Type II diabetes mellitus patients but both FBG and PPG were found to be correlated with HbA1c levels. Also if FBG, PPG, BMI and duration of diabetes are known, HbA1c levels can be predicted, showing that these variables can be used to monitor and assess the morbidity of diabetes in these patients.



Type II Diabetes Mellitus, NIDDM, BMI, Blood glucose, HbA1c, Indian population

Full Text:



WHO Diabetes country profiles

Mohan V, Anjana RM, Pradeep R, Unnikrishnan R, Kaur T, Das AK. The ICMR INDIA B Study-A Compendum of Type 2 Diabetes in India: Lesson learnt from the nation; Chapter 241:1104-1110.

Ramachandran A, Snehalatha C, Kapur A, Vijay V, Mohan V, Das AK et al. Diabetes Epidemiology Study Group in India(DESI).High prevalence of diabetes and impaired glucose tolerance in India:National Urban Diabetes Survey.Diabetologia.2001;44:1094-1101.

Sadikot SM, Nigam A, Das S, Bajaj S, Zargar AH, Prasannakumar KM et al. Diabetes IndiaThe burden of Diabetes and Impaired glucose tolerance in India using the WHO 1999 criteria: Prevalence of Diabetes in India Study(PODIS).Diabetes Res Clin Pract.2004;66:301-307.

Singh RB, Pella D, Mechinova V, Kartikey K, Demeester F, Tomar RS et al. Five City Study Group.Prevalence of obesity,physical inactivity and undernutrition ,a triple burden of diseases during transition in a developing country. Acta Cardiol.2007 Apr;62(2):119-27.

Mohan V, Mathur P, Deepa R, Deepa M,Shukla DK, Menon GR, Ananad K, Desai NG, Joshi PP, Mahanta J, Thankappam KR, Shah B. Urban rural differences in India-the WHO-ICMR Indian NCD risk factor surveillance .Diabetes research and clinical practice.2008;80: 159-168.

World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Report of a WHO/IDF Consultation,Geneva,WHO.2006:39.

World Health Organization. Use of Glycated Hemoglobin in the diagnosis of Diabetes Mellitus: Abbreviated report of a WHO consultation.Geneva,WHO.2011:1-25.

D’Embden M. Glycated haemoglobin for the diagnosis of diabetes.Australian Prescriber.2014;37(3):98-100.

American Diabetes Association. Standards of medical care in diabetes-2012.Diabetes Care.2012;35 Suppl 1:511-63.

Nathan DM, Turgeon H, Regan S. Relationship between glycated haemoglobin levels and mean glucose levels over time.Diabetologia.2007;50:2239-44.

Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem.1969;6:24-7.

Bisse E, Abraham EC. New less temperature sensitive microchromatographic method for the separation and quantitation of glycosylated haemoglobins using a non-cyanide buffer system.J.Chromatogr.1985;344:81-91.

Najeeb Q, Singh J, Pandey R, Mahajan R. A comparative study of fasting, postprandial blood glucose and glycosylated haemoglobin for diagnosing diabetes mellitus in staff members of MMIMSR, Mullana, Ambala. Medical Journal of Dr D.Y.Patil University. March-April 2015;8(2):158-164.

Arnetz B.B, Kallner A, Theorell T. The influence of aging on HbA1c.J.Gerontol.1982;37:648-650.

Kilpatrick ES, Dominiczak MH, Small M. The effects of aging on glycation and the interpretation of glycemic control in Type 2 diabetes.Q.J.Med.1996;89:307-312.

Kabadi UM. Glycosylation of proteins. Lack of influence on aging.Diabetes Care.1998;11:421-432.

Colditz GA, Willett WC, Stamofer MJ, Masson JE, Hennekens CH, Arky RA, Seizer FE. Weight as a risk factor for clinical diabetes in women. Am J Epidemniol.1990;132(3):501-513.

Guilherme A, Virbasius JV, Puri V, Czech MP. Adipocyte dysfunction linking obesity to insulin resistance and Type 2 diabetes. Nat Rev Mol Cell Biol.2008;10(4):412-419.

Gupta S, Puppalwar PV, Chalak A. Correlation of fasting and post meal plasma glucose level to increased HbA1c levels in type 2 diabetes J Adv Med.2014;1(2):127-131.

Ghazanfari Z, Haghdoost AA, Alizadeh SM, Atapour J, Zolala F.A comparison of HbA1c and fasting blood sugar tests in general population.Int J Prev Med.2010;1(3):187-194.

Rohfling CL, Wiedmeyer HM, Little RR, Engkand JD, Tennill A, Glodstein DE. Defining the relationship between plasma glucose and HbA1c.Diabetes Care;25(2):275-273.

Tahara, Shima K. The response of GHb to stepwise plasma glucose change over time in diabetes patients. Diabetes Care.1993;16:1313-1314.

Langdraf R. The relationship of postprandial glucose to HbA1c.Diabetes Metab Res Rev.2004 Nov-Dec;20(2):S9-S12.


  • There are currently no refbacks.